8.81
+0.32(+3.77%)
Currency In USD
| Previous Close | 8.49 |
| Open | 8.51 |
| Day High | 8.84 |
| Day Low | 8.38 |
| 52-Week High | 58.23 |
| 52-Week Low | 6.32 |
| Volume | 1.49M |
| Average Volume | 1.29M |
| Market Cap | 360.47M |
| PE | -11.01 |
| EPS | -0.8 |
| Moving Average 50 Days | 10.14 |
| Moving Average 200 Days | 24.29 |
| Change | 0.32 |
If you invested $1000 in RxSight, Inc. (RXST) since IPO date, it would be worth $550.63 as of August 20, 2025 at a share price of $8.81. Whereas If you bought $1000 worth of RxSight, Inc. (RXST) shares 3 years ago, it would be worth $652.59 as of August 20, 2025 at a share price of $8.81.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
RxSight, Inc. to Present at the Wells Fargo Healthcare Conference
GlobeNewswire Inc.
Aug 14, 2025 8:05 PM GMT
ALISO VIEJO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upc
RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors
GlobeNewswire Inc.
Aug 04, 2025 12:05 PM GMT
ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced the appointmen
RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire Inc.
Jul 24, 2025 8:05 PM GMT
ALISO VIEJO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results